COR Cencora Inc.

  1. Stocks
  2. Healthcare
  3. NYSE: COR

Price (delayed)

$281.1

Market cap

$54.69B

P/E Ratio

21.43

Dividend/share

$2.35

EPS

$13.12

Enterprise value

$64.9B

?
Relative Growth: Rel. Growth: 76
Relative Strength: Rel. Strength: 26
Relative Valuation: Rel. Valuation: 83
Relative Profitability: Rel. Profitability: 68

amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in ...

Highlights
The equity has soared by 78% from the previous quarter
The company's net income has surged by 57% QoQ and by 51% YoY
The company's debt has surged by 58% YoY and by 56% QoQ
Sector: Healthcare
Industry: Medical Distribution
Website: https://www.amerisourcebergen.com/
Peers: EQIX OLP STWD ALX

Key stats

What are the main financial stats of COR

COR stock price

How has the Cencora stock price performed over time
Intraday
3.62%
1 week
-0.13%
1 month
2.25%
1 year
-4.1%
YTD
-16.77%
QTD
-10.52%

Financial performance

How have Cencora's revenue and profit performed over time
Revenue
$328.68B
Gross profit
$12.52B
Operating income
$2.79B
Net income
$2.55B
Gross margin
3.8%
Net margin
0.8%
The company's net margin has surged by 60% QoQ and by 60% YoY
The company's net income has surged by 57% QoQ and by 51% YoY
COR's gross profit is up by 19% year-on-year and by 4.4% since the previous quarter
The company's gross margin rose by 12% YoY and by 2.7% QoQ

Price vs fundamentals

How does COR's price correlate with its fundamentals

Growth

What is Cencora's growth rate over time

Valuation

What is Cencora stock price valuation
COR P/E details
P/E
21.43
P/B
16.09
P/S
0.17
EV/EBIT
16.75
EV/EBITDA
14.69
EV/Sales
0.2
COR's EPS has surged by 57% since the previous quarter and by 51% year-on-year
COR's P/E is 38% below its last 4 quarters average of 33.4 and 16% below its 5-year quarterly average of 24.6
The price to book (P/B) is 85% lower than the 5-year quarterly average of 102.9 and 49% lower than the last 4 quarters average of 30.5
The equity has soared by 78% from the previous quarter
The P/S is 20% below the 5-year quarterly average of 0.2 and 20% below the last 4 quarters average of 0.2
Cencora's revenue has increased by 6% YoY

Efficiency

How efficient is Cencora business performance
The ROE has dropped by 52% year-on-year but it has grown by 14% since the previous quarter
COR's return on sales has surged by 50% since the previous quarter and by 50% year-on-year
The company's return on assets has surged by 50% QoQ and by 32% YoY
Cencora's ROIC has decreased by 31% YoY but it has increased by 13% from the previous quarter

Dividends

What is COR's dividend history
Dividend details
DPS
$2.35
Dividend yield
0.84%
Payout ratio
17.9%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Cencora financials performed over time
COR's total assets is 4.6% greater than its total liabilities
COR's total assets is up by 15% year-on-year and by 4.2% since the previous quarter
Cencora's total liabilities has increased by 12% YoY and by 2.4% from the previous quarter
The equity has soared by 78% from the previous quarter
The company's debt has surged by 58% YoY and by 56% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.